Grandfield & Dodd LLC Has $14,045,000 Position in Dentsply International Inc. (XRAY)
Grandfield & Dodd LLC boosted its stake in Dentsply International Inc. (NASDAQ:XRAY) by 0.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 226,388 shares of the company’s stock after buying an additional 288 shares during the period. Dentsply International makes up about 2.0% of Grandfield & Dodd LLC’s holdings, making the stock its 15th largest position. Grandfield & Dodd LLC owned about 0.10% of Dentsply International worth $14,045,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp increased its position in shares of Dentsply International by 58.3% in the first quarter. State Street Corp now owns 10,034,613 shares of the company’s stock valued at $618,429,000 after buying an additional 3,696,056 shares in the last quarter. Jackson Square Partners LLC increased its stake in shares of Dentsply International by 95.8% in the first quarter. Jackson Square Partners LLC now owns 6,300,098 shares of the company’s stock worth $388,275,000 after buying an additional 3,082,688 shares during the period. BlackRock Institutional Trust Company N.A. increased its stake in shares of Dentsply International by 71.9% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 6,691,695 shares of the company’s stock worth $412,409,000 after buying an additional 2,798,549 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Dentsply International by 799.7% in the first quarter. JPMorgan Chase & Co. now owns 2,696,746 shares of the company’s stock worth $166,202,000 after buying an additional 2,396,999 shares during the period. Finally, Bessemer Group Inc. increased its stake in shares of Dentsply International by 3,260.7% in the first quarter. Bessemer Group Inc. now owns 1,778,420 shares of the company’s stock worth $109,604,000 after buying an additional 1,725,502 shares during the period. Institutional investors own 94.58% of the company’s stock.
Shares of Dentsply International Inc. (NASDAQ:XRAY) traded down 0.74% during trading on Monday, reaching $58.99. The company’s stock had a trading volume of 1,427,535 shares. The company has a 50 day moving average of $60.27 and a 200-day moving average of $61.45. Dentsply International Inc. has a 12-month low of $51.28 and a 12-month high of $65.83.
Dentsply International (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, August 5th. The company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.06. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The company earned $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the company earned $0.73 earnings per share. The firm’s revenue was up 46.4% on a year-over-year basis. Equities analysts anticipate that Dentsply International Inc. will post $2.76 earnings per share for the current year.
The company also recently declared a dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be paid a dividend of $0.0775 per share. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s payout ratio is presently 14.49%.
A number of analysts have recently issued reports on XRAY shares. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a research report on Sunday, June 5th. Piper Jaffray Cos. started coverage on Dentsply International in a research report on Monday, June 13th. They set an “overweight” rating and a $70.00 price target for the company. Barrington Research downgraded Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Zacks Investment Research downgraded Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Finally, Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $66.82.
In other news, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total value of $305,600.00. Following the completion of the sale, the vice president now directly owns 34,370 shares of the company’s stock, valued at approximately $2,100,694.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Maureen J. Macinnis sold 17,650 shares of the firm’s stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $60.61, for a total value of $1,069,766.50. Following the completion of the sale, the senior vice president now directly owns 19,630 shares of the company’s stock, valued at $1,189,774.30. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.
Dentsply International Company Profile
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.